Search
Search Results
-
-
-
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
People with diabetes are at greater risk for negative outcomes from COVID-19. Though this risk is multifactorial, poor glycaemic control before and...
-
The competitive athlete with type 1 diabetes
Regular exercise is important for health, fitness and longevity in people living with type 1 diabetes, and many individuals seek to train and compete...
-
Altitude illnesses
Millions of people visit high-altitude regions annually and more than 80 million live permanently above 2,500 m. Acute high-altitude exposure can...
-
-
-
Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial
Aims/hypothesisThe aim of this randomised, crossover trial was to compare cognitive functioning and associated brain activation patterns during...
-
Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study
PurposeTo evaluate factors influencing the insulin and levothyroxine requirement in patients with autoimmune polyglandular syndrome type 3 (APS-3)...
-
Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes
BackgroundGlucose-lowering therapy (GLT) should be individualized in older patients with type 2 diabetes (T2D) according to their health status and...
-
Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial
Aims/hypothesisEvidence for the effectiveness of interstitial glucose monitoring in individuals with type 1 diabetes using multiple daily injection...
-
Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review
In recent years, the development of basal insulin therapies has focused on insulin analogues that have longer durations of action and more...
-
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
Background and AimThe coronavirus disease 2019 (COVID-19) outbreak has rapidly crossed international boundaries and placed increasing demands on...
-
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Aims/hypothesisThe aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk...
-
-
Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes
The recent introduction of the second-generation long-acting analogue insulins degludec and insulin glargine U300 have increased the choice of basal...
-
Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland
AimsThe uptake of continuous subcutaneous insulin infusion (CSII) is low in adults with type 1 diabetes mellitus (T1DM) in Ireland, compared to other...
